Hemispherx (HEB) Receives Favorable Response from FDA Seattle Office Related to Ampligen Manufacturing Response
Tweet Send to a Friend
Hemispherx Biopharma, Inc. (Amex: HEB), announced that the Company, via its manufacturing subcontractor, received a favorable response from the FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
